CHICAGO --- Jill C. Pelling has been named the Joseph C. Calandra Research Professor of Pathology and Toxicology at the Northwestern University Feinberg School of Medicine.
Pelling is a translational cancer biologist working in the field of signal transduction and development of natural products for cancer chemoprevention. She is associate director for translational research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. She is also the associate director for Northwestern's Center for Cancer Nanotechnology Excellence and principal investigator of the NCI Training Program in Signal Transduction and Cancer.
Pelling is working with a plant flavanoid called apigenin which is present in leafy vegetables and fruits and has been shown to inhibit UV and chemically-induced mouse skin tumorigenesis. Her studies are relevant to several areas of biomedical research including cancer biology, angiogenesis, cell signaling and development of novel chemopreventive agents. Her work has been funded by the National Cancer Institute for 21 years.
She is on the editorial board of Molecular Carcinogenesis and Nutrition and Cancer and is a former member of the editorial board of Carcinogenesis. She is a member of the American Association for Cancer Research, the American Society for Photobiology and Women in Cancer Research.
Prior to joining Northwestern's Feinberg School of Medicine in 2004, Pelling was on the faculty at the University of Nebraska Medical Center and the University of Kansas Medical Center where she served for eight years as director for basic research for the Kansas Cancer Institute. She received an NIH Research Career Development Award and the Distinguished Teaching Award from the University of Nebraska.